Yumi is a project coordinator and PhD student at the Kirby Institute UNSW Sydney, currently working across multiple HCV and prison-related research studies and initiatives. Yumi’s PhD focusses on strategies to enhance access to HCV testing and treatment for prisoners, with a particular focus on point-of-care testing and education.

Michael is a PhD candidate at the Burnet Institute and Monash University’s School of Public Health and Preventative Medicine. Using prospective cohort data, Michael’s PhD investigates the impact of medication for opioid use disorder on post-release substance use, health and health service utilisation.

Dr Lise Lafferty is a Research Fellow at the Centre for Social Research in Health, UNSW Sydney. She is a qualitative social health researcher, with research interests in hepatitis C, people who inject drugs, prisoner health, and Aboriginal health.

Behzad is a clinical epidemiologist, and a Senior Lecturer in the Kirby Institute (UNSW Sydney). He trained as a Medical Practitioner and has a PhD in Medicine. His main areas of research include epidemiology and clinical management of viral hepatitis, particularly in prison, and among people who inject drugs.

Yumi is a project coordinator and PhD student at the Kirby Institute UNSW Sydney, currently working across multiple HCV and prison-related research studies and initiatives. Yumi’s PhD focusses on strategies to enhance access to HCV testing and treatment for prisoners, with a particular focus on point-of-care testing and education.

Samir Kamat, B.A. is a second year medical student at the Icahn School of Medicine and a graduate of Rutgers University. He has previously interned at the Drug Policy Alliance, White House Office of American Innovation, and New Jersey Reentry Corporation on issues around criminal justice reform and addiction.

Dr. Sazzad is a Scientia PhD candidate in the Kirby Institute, UNSW. His PhD topics includes hepatitis C transmission in prison through whole-genome oxford-nanopore next-generation sequencing, identifying the non-injecting risk practice through qualitative methods and tracking trends of HCV epidemic through population genetics/bioinformatics. He is a Bangladeshi physician/epidemiologist.